Urologist Hadley Wood, MD, discusses her vision as Urology’s new editor-in-chief and the link between this role, her clinical practice and research program.Read More
Cleveland Clinic investigators have launched a novel clinical trial to assess the efficacy of low-intensity focused shockwave therapy and radial wave therapy for treatment of erectile dysfunction or chronic pelvic pain in prostate cancer survivors.
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
What new findings reveal about intraoperative sacral neuromodulation lead placement in patients receiving the treatment for overactive bladder.
Cleveland Clinic urology researchers have made a startling discovery that holds major potential for noninvasive treatment of idiopathic male infertility.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Why researchers are hopeful that photonic lithotripsy, an innovative approach to fragmenting kidney stones, could be an alternative for patients who don’t succeed with current interventions.
Aquablation therapy, indicated for men with benign prostatic hyperplasia, is designed to remove tissue with fewer side effects, giving the therapy an advantage over some existing procedures.
Tyrosine kinase inhibitors in the neoadjuvant setting are associated with greater use of partial nephrectomy when treating patients diagnosed with renal masses in a solitary kidney, according to the findings of a new Cleveland Clinic study.
Learn more about the anterior rectus sheath approach and why kidney transplant surgeons at Cleveland Clinic are using it in nearly 90% of cases.
Ultrasound-guided prostate SBRT can aid patients being treated for prostate cancer.
A Cleveland Clinic study finds that race-modified kidney function equations may have contributed to lower use of nephron-sparing surgical approaches in Black patients.